Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).
An Update on Heart Failure in Primary Care
Allergen Introduction – Practical Tips for GPs
Falls Prevention – A Practical, Evidence-Based Update on What Really Works
The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns
expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland